Capecitabine, DNA/RNA Synthesis Inhibitor
Por um escritor misterioso
Descrição
Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
XELODA® - Cancer Therapy Advisor
Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients - American Journal of Transplantation
Capecitabine-d11, Stable Isotope
Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes
Emerging strategies for cancer therapy by ATR inhibitors - Yano - 2023 - Cancer Science - Wiley Online Library
Capecitabine, DNA, RNA and Protein Synthesis Inhibitors
Capecitabine, DNA, RNA and Protein Synthesis Inhibitors
Oxaliplatin, CAS#:63121-00-6
Full article: Facile construction of dual-drug loaded nanoparticles for improvement synergistic chemotherapy in prostate cancer
Frontiers Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment
Cellular responses to replication stress: Implications in cancer biology and therapy.
de
por adulto (o preço varia de acordo com o tamanho do grupo)
